High Potent Active Pharmaceutical Ingredient (HPAPI) Market Growth Analysis Report 2021 – 2028
Ameco Research has recently published a research report on the High Potent Active Pharmaceutical Ingredient (HPAPI) Market for the forecast period of 2021-2028, wherein, the global market has been analyzed and assessed in an extremely comprehensive manner. The research report on the High Potent Active Pharmaceutical Ingredient (HPAPI) Market offers an extensive analysis of how the postoperative pain therapeutics landscape would evolve through 2028.
The research study on the High Potent Active Pharmaceutical Ingredient (HPAPI) Market analyzes key drivers upholding product sales and prominent trends shaping the growth of the market. The research study not only focuses on the latent opportunities for the key stakeholders of the market, but also sheds light on the notable developments and future scope for innovation in the landscape.
Download Sample Report Copy Of This Report From Here: https://www.amecoresearch.com/sample/276609
The report starts off with a quick executive summary, wherein, key takeaways have been highlighted for the readers to have a sneak peak at the key market segments. The research study by Ameco Research on the market also talks about the macroeconomic and microeconomic factors having deep-rooted influences on global market growth. The research study on the High Potent Active Pharmaceutical Ingredient (HPAPI) Market also offers a regional analysis, wherein, demand across every region has been comprehensively analyzed.
Key Vendors Included as below:
BASF SE, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Pfizer, Inc., Merck & Co., Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., and Cambrex
Key Questions Answered in the Report
The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-
- What is the overall structure of the market?
- What was the historical value and what is the forecasted value of the market?
- What are the key product level trends in the market?
- What are the market level trends in the market?
- Which of the market players are leading and what are their key differential strategies to retain their stronghold?
- Which are the most lucrative regions in the market space?
Market Segment for this report as below:
Product Type Segments
· Synthetic
· Biotech
Manufacturer Type Segments
· In-house
· Outsourced
Drug Type Segments
· Innovative
· Generic
Application Segments
· Oncology
· Hormonal Disorders
· Glaucoma
· Others
Table of Content:
CHAPTER 1. Industry Overview of High Potent Active Pharmaceutical Ingredient (HPAPI) Market
1.1. Definition and Scope
1.1.1. Definition of High Potent Active Pharmaceutical Ingredient (HPAPI)
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global High Potent Active Pharmaceutical Ingredient (HPAPI) market
1.2. Summary
1.2.1. Executive Summary
1.2.2. High Potent Active Pharmaceutical Ingredient (HPAPI) Market By Product Type
1.2.3. High Potent Active Pharmaceutical Ingredient (HPAPI) Market By Manufacturer Type
1.2.4. High Potent Active Pharmaceutical Ingredient (HPAPI) Market By Drug Type
1.2.5. High Potent Active Pharmaceutical Ingredient (HPAPI) Market By Application
1.2.6. High Potent Active Pharmaceutical Ingredient (HPAPI) Market By Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Sources
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of High Potent Active Pharmaceutical Ingredient (HPAPI) Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for High Potent Active Pharmaceutical Ingredient (HPAPI) Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material Cost
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2020
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2020
4.2. R&D Status of Major Manufacturers in 2020
CHAPTER 5. High Potent Active Pharmaceutical Ingredient (HPAPI) Market By Product Type
5.1. Introduction
5.2. High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) By Product Type
5.2.1. High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
5.2.2. Synthetic
5.2.2.1. Synthetic Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
5.2.3. Biotech
5.2.3.1. Biotech Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
CHAPTER 6. High Potent Active Pharmaceutical Ingredient (HPAPI) Market By Manufacturer Type
6.1. Introduction
6.2. High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) By Manufacturer Type
6.2.1. High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Manufacturer Type, 2017-2028
6.2.2. In-house
6.2.2.1. In-house Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
6.2.3. Outsourced
6.2.3.1. Outsourced Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
CHAPTER 7. High Potent Active Pharmaceutical Ingredient (HPAPI) Market By Drug Type
7.1. Introduction
7.2. High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue By Drug Type
7.2.1. High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast, By Drug Type, 2017-2028
7.2.2. Innovative
7.2.2.1. Innovative Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
7.2.3. Generic
7.2.3.1. Generic Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
CHAPTER 8. High Potent Active Pharmaceutical Ingredient (HPAPI) Market By Application
8.1. Introduction
8.2. High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue By Application
8.2.1. High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast, By Application, 2017-2028
8.2.2. Oncology
8.2.2.1. Oncology Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
8.2.3. Hormonal Disorders
8.2.3.1. Hormonal Disorders Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
8.2.4. Glaucoma
8.2.4.1. Glaucoma Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
8.2.5. Others
8.2.5.1. Others Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
CHAPTER 9. North America High Potent Active Pharmaceutical Ingredient (HPAPI) Market By Country
9.1. North America High Potent Active Pharmaceutical Ingredient (HPAPI) Market Overview
9.2. U.S.
9.2.1. U.S. High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
9.2.2. U.S. High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Manufacturer Type, 2017-2028
9.2.3. U.S. High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Drug Type, 2017-2028
9.2.4. U.S. High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
9.3. Canada
9.3.1. Canada High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
9.3.2. Canada High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Manufacturer Type, 2017-2028
9.3.3. Canada High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Drug Type, 2017-2028
9.3.4. Canada High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
9.4. North America PEST Analysis
CHAPTER 10. Europe High Potent Active Pharmaceutical Ingredient (HPAPI) Market By Country
10.1. Europe High Potent Active Pharmaceutical Ingredient (HPAPI) Market Overview
10.2. U.K.
10.2.1. U.K. High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
10.2.2. U.K. High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Manufacturer Type, 2017-2028
10.2.3. U.K. High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Drug Type, 2017-2028
10.2.4. U.K. High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
10.3. Germany
10.3.1. Germany High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
10.3.2. Germany High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Manufacturer Type, 2017-2028
10.3.3. Germany High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Drug Type, 2017-2028
10.3.4. Germany High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
10.4. France
10.4.1. France High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
10.4.2. France High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Manufacturer Type, 2017-2028
10.4.3. France High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Drug Type, 2017-2028
10.4.4. France High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
10.5. Spain
10.5.1. Spain High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
10.5.2. Spain High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Manufacturer Type, 2017-2028
10.5.3. Spain High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Drug Type, 2017-2028
10.5.4. Spain High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
10.6. Rest of Europe
10.6.1. Rest of Europe High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
10.6.2. Rest of Europe High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Manufacturer Type, 2017-2028
10.6.3. Rest of Europe High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Drug Type, 2017-2028
10.6.4. Rest of Europe High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific High Potent Active Pharmaceutical Ingredient (HPAPI) Market By Country
11.1. Asia Pacific High Potent Active Pharmaceutical Ingredient (HPAPI) Market Overview
11.2. China
11.2.1. China High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
11.2.2. China High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Manufacturer Type, 2017-2028
11.2.3. China High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Drug Type, 2017-2028
11.2.4. China High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
11.3. Japan
11.3.1. Japan High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
11.3.2. Japan High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Manufacturer Type, 2017-2028
11.3.3. Japan High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Drug Type, 2017-2028
11.3.4. Japan High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
11.4. India
11.4.1. India High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
11.4.2. India High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Manufacturer Type, 2017-2028
11.4.3. India High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Drug Type, 2017-2028
11.4.4. India High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
11.5. Australia
11.5.1. Australia High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
11.5.2. Australia High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Manufacturer Type, 2017-2028
11.5.3. Australia High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Drug Type, 2017-2028
11.5.4. Australia High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
11.6. South Korea
11.6.1. South Korea High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
11.6.2. South Korea High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Manufacturer Type, 2017-2028
11.6.3. South Korea High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Drug Type, 2017-2028
11.6.4. South Korea High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
11.7.2. Rest of Asia-Pacific High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Manufacturer Type, 2017-2028
11.7.3. Rest of Asia-Pacific High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Drug Type, 2017-2028
11.7.4. Rest of Asia-Pacific High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America High Potent Active Pharmaceutical Ingredient (HPAPI) Market By Country
12.1. Latin America High Potent Active Pharmaceutical Ingredient (HPAPI) Market Overview
12.2. Brazil
12.2.1. Brazil High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
12.2.2. Brazil High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Manufacturer Type, 2017-2028
12.2.3. Brazil High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Drug Type, 2017-2028
12.2.4. Brazil High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
12.3. Mexico
12.3.1. Mexico High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
12.3.2. Mexico High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Manufacturer Type, 2017-2028
12.3.3. Mexico High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Drug Type, 2017-2028
12.3.4. Mexico High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
12.4. Rest of Latin America
12.4.1. Rest of Latin America High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
12.4.2. Rest of Latin America High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Manufacturer Type, 2017-2028
12.4.3. Rest of Latin America High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Drug Type, 2017-2028
12.4.4. Rest of Latin America High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa High Potent Active Pharmaceutical Ingredient (HPAPI) Market By Country
13.1. Middle East & Africa High Potent Active Pharmaceutical Ingredient (HPAPI) Market Overview
13.2. GCC
13.2.1. GCC High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
13.2.2. GCC High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Manufacturer Type, 2017-2028
13.2.3. GCC High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Drug Type, 2017-2028
13.2.4. GCC High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
13.3. South Africa
13.3.1. South Africa High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
13.3.2. South Africa High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Manufacturer Type, 2017-2028
13.3.3. South Africa High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Drug Type, 2017-2028
13.3.4. South Africa High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
13.4.2. Rest of Middle East & Africa High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Manufacturer Type, 2017-2028
13.4.3. Rest of Middle East & Africa High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Drug Type, 2017-2028
13.4.4. Rest of Middle East & Africa High Potent Active Pharmaceutical Ingredient (HPAPI) Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of High Potent Active Pharmaceutical Ingredient (HPAPI) Market
14.1. High Potent Active Pharmaceutical Ingredient (HPAPI) Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global High Potent Active Pharmaceutical Ingredient (HPAPI) market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements
CHAPTER 15. Company Profile
15.1. BASF SE
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (US$ Bn), 2020
15.1.3.2. BASF SE 2020 High Potent Active Pharmaceutical Ingredient (HPAPI) Business Regional Distribution
15.1.4. Product Type/ Service and Specification
15.1.5. Recent Developments & Business Strategy
15.1.6. Manufacturing Plant Footprint Analysis
15.2. Dr. Reddy’s Laboratories Ltd.
15.3. Pfizer, Inc.
15.4. Sanofi S.A.
15.5. Merck & Co., Inc.
15.6. Novartis AG
15.7. F. Hoffmann-La Roche Ltd.
15.8. Bristol-Myers Squibb Company
15.9. Boehringer Ingelheim International GmbH
15.10. Cambrex
15.11. Cipla Inc.
Ask Query Here: Sales@amecoresearch.com
To Purchase this Premium Report@ https://www.amecoresearch.com/buy/276609
About Ameco Research:
The complete information about our alliance publishers and the business verticals they cater to helps us in appropriately responding to our client requirements and identifying the potential opportunities in the market and suggest the research that can best suit client’s requirement. Our comprehensive list of research reports boasts a complete collection of database casing almost every market category and sub-category.
For Latest Update Follow Us on Twitter and, LinkedIn
Contact Us:
Mr. Richard Johnson
Ameco Research
India: +918983225533
E-mail: sales@amecoresearch.com
